Weiss Ratings Upgrades Maximus (NYSE:MMS) to Buy (B-)

Key Points

• Weiss Ratings upgraded Maximus from a "hold (c+)" to a "buy (b-)" rating, reflecting a positive outlook on the company's performance.
• Zacks Research also raised Maximus' rating from "hold" to "strong-buy," indicating strong confidence from multiple analysts as they anticipate a consensus price target of $90.00.
• The company reported a significant earnings per share of $2.16 for the last quarter, exceeding estimates, alongside a revenue increase of 2.5% year-over-year, highlighting its continued growth momentum.

Maximus (NYSE:MMS - Get Free Report) was upgraded by stock analysts at Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating in a research note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Zacks Research raised Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $90.00.

Maximus Trading Up 0.0%

Maximus stock opened at $90.25 on Wednesday. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The business's fifty day simple moving average is $86.17 and its two-hundred day simple moving average is $75.81. Maximus has a 12 month low of $63.77 and a 12 month high of $93.73. The company has a market capitalization of $5.09 billion, a price-to-earnings ratio of 16.62 and a beta of 0.57.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the company posted $1.74 earnings per share. The company's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, equities analysts predict that Maximus will post 6.15 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the transaction, the insider owned 13,508 shares of the company's stock, valued at approximately $1,227,336.88. This represents a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Fuller & Thaler Asset Management Inc. lifted its holdings in Maximus by 40.0% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock valued at $117,921,000 after acquiring an additional 494,372 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Maximus by 20.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock valued at $115,620,000 after acquiring an additional 288,990 shares during the period. Van Berkom & Associates Inc. lifted its holdings in Maximus by 1.5% in the first quarter. Van Berkom & Associates Inc. now owns 1,275,394 shares of the health services provider's stock valued at $86,969,000 after acquiring an additional 18,976 shares during the period. AQR Capital Management LLC raised its stake in shares of Maximus by 177.2% in the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider's stock worth $79,341,000 after buying an additional 750,031 shares during the period. Finally, Reinhart Partners LLC. raised its stake in shares of Maximus by 0.3% in the second quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider's stock worth $64,154,000 after buying an additional 2,345 shares during the period. Institutional investors own 97.21% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.